| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267651.1 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.038566515 |
Resistant |
| ENSG00000267651.1 |
Tanespimycin |
Brain lower grade glioma |
0.035851688 |
Resistant |
| ENSG00000267651.1 |
Tanespimycin |
Lung squamous cell carcinoma |
0.005366033 |
Resistant |
| ENSG00000267651.1 |
Tanespimycin |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030428488 |
Sensitive |
